López-López D, Agrasar-Cruz C, Bautista-Casasnovas A, Álvarez-Castro CJ

Language: Spanish
References: 26
Page: 14-19
PDF size: 332.23 Kb.

ABSTRACT

Introduction: Plantar warts often are refractory to any treatment and can last for decades in adults. Recalcitrant warts are defined as those that have persisted for more than two years, or after at least two treatment modalities. Methods: A total of 15 consecutive patients with recalcitrant plantar warts were included in this preliminary study. The treatment consisted of applying one to two sessions that comprised compounding 1% cantharidin, 5% of podophyllotoxin, and 30% salicylic acid (CPS), with an interval between applications of four weeks. Results: With treatment and subsequent follow-up for six months, there was complete eradication of lesions in 15 patients, eight (53.3%) required a single application of the solution, and seven (46.7%) two applications, with no side effects. Patient satisfaction related to treatment was measured by a visual analog scale (VAS) of 10 cm in length, with an average score 9.73 ± 0.46, and all said they would proceed with the treatment again if necessary. Conclusions: Topical treatment by compounding is safe, effective, and a promising therapeutic modality when applied in recalcitrant plantar warts.

REFERENCES

1. Lio P. Warts, molluscum and things that go bump on the skin: A practical guide. Arch Dis Child Educ Pract Ed. 2007;92(4):119-24.

2. Chern E, Yu-SWen Cheng. Treatment of recalcitrant periungual warts with cimetidine in pediatrics. J Dermatol Treat. 2010;21(5):314-6.

3. Lipke MM. An Armamentarium of Wart Treatments. Clin Med Res. 2006;4(4):273-93.

4. Ciconte A, Campbell J, Tabrizi S, Garland S, Marks R. Warts are not merely blemishes on the skin: A study on the morbidity associated with having viral cutaneous warts. Australas J Dermatol. 2003;44(3):169-73.

5. Fuchs SM, Fluhr W, Bankova L, Tittelbach J, Hoffmann G, Elsner P. Photodynamic therapy (PDT) and waterfiltered infrared A (wIRA) in patients with recalcitrant common hand and foot warts. Ger Med Sci. 2004;2:Doc08.

6. Kaçar N, Ta,clı L, Korkmaz S, Ergin S, Erdo˘gan B,S. Cantharidin-podophylotoxin- salicylic acid versus cryotherapy in the treatment of plantar warts: a randomized prospective study. J Eur Acad Dermatol Venereol. 2012;26(7):889-93.

7. Rivera A, Tyring SK. Therapy of cutaneous human papilloma¬ virus infections. Dermatol Ther. 2004;17(6):441-8.

8. Glass AT, Solomon BA. Cimetidine therapy for recalcitrant warts in adults. Arch Dermatol. 1996;132(6):680-2.

9. Stockfleth E. Human papilloma virus infections. En: Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, eds. Braun-Falco’s Dermatology. 3.a ed. Italia: Springer; 2009. p. 64-73.

10. Kuykendall-Ivy TD, Johnson SM. Evidence-based review of management of nongenital cutaneous warts. Cutis. 2003;71(3):213-22.

11. El-Tonsy MH, Anbar TE, El-Domyati M, Barakat M. Density of viral particles in pre and post Nd: YAG laser hyperthermia therapy and cryotherapy in plantar warts. Int J Dermatol. 1999;38(5):393.

12. Cance DJ, Gadner SD. Papovaviruses: Papillomaviruses and Polyomaviruses, in Principles and Practice of Clinical Virology. En: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Nueva York: John Wiley & Sons; 1997. P. 491.

13. Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2006;(3):CD001781.

14. Yang F, Qin X, Cheng Z, Xie S. Intralesional pingyangmycin treatment for resistant plantar warts. Dermatology. 2010;220(2):110-3.

15. Becerro de Bengoa Vallejo R, Losa Iglesias ME, Gómez-Martín B, Sánchez Gómez R, Sáez Crespo A. Application of cantharidin and podophyllotoxin for the treatment of plantar warts. J Am Podiatr Med Assoc. 2008;98(6):445-50.

16. Day RM, Harbord M, Forbes A, Segal AW. Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. J Immunol Methods. 2001;257 (1- 2):213-20.

17. Epstein WL, Kligman AM. Treatment of warts with cantharidin. AMA Arch Derm. 1958;77(5):508-11.

18. Moed L, Shwayder TA, Chang MW. Cantharidin revisited. Arch Dermatol. 2001;137(10):1357-60.

19. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum 5. contagiosum: Experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43(3):503-7.

20. Canpolat F, Cemil BC, Eskio˘glu F. Liquid nitrogen cryothearpy of plantar verrucae: cryoblast is more effective than the cryo-spray. Eur J Dermatol. 2008;18(3):341-2.

21. Ahmed I, Agarwal S, Ilchyshyn A, Charles-Holmes S, Berth-Jones J. Liquid nitrogen cryotherapy of common warts: cryo-spray vs. cotton wool bud. Br J Dermatol. 2001;144(5):1006-9.

22. Kartal Durmazlar SP, Atacan D, Eskioglu F. Cantharidin treatment for recalcitrant facial flat warts: a preliminary study. J Dermatolog Treat. 2009;20(2):114-9.

23. Hernando T, Rico-Villademoros F. Documentos esenciales para el desarrollo de un ensayo clínico. En: Hernández G, Moreno A, Zaragoza F, Porras A, eds. Tratado de Medicina Farmacéutica. Madrid: Panamericana; 2010. p. 211-22.

24. Lim JT, Goh CL. Carbon dioxide laser treatment of periungual and subungual viral warts. Australas J Dermatol. 1992;33(2):87-91.

25. Logan RA, Zachary CB. Outcome of carbon dioxide laser therapy for persistent cutaneous viral warts. Br J Dermatol.1989;121(1):99-105.

26. Oni G, Mahaffey PJ. Treatment of recalcitrant warts with the carbon dioxide laser using an excision technique. J Cosmet Laser Ther. 2011; 13(5):231-6.